SCM
IDYA icon

Soleus Capital Management’s IDEAYA Biosciences IDYA Stock Holding History

Soleus Capital Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100,000
Closed -$2.72M – 107
2025
Q3 		$2.72M Sell
100,000
-150,000
-60% -$3.63M 0.15% 68
2025
Q2 		$5.25M Buy
+250,000
New +$4.8M 0.36% 52
2024
Q4 		– Sell
-1,049,314
Closed -$33.2M – 94
2024
Q3 		$33.2M Buy
1,049,314
+355,245
+51% +$13.5M 2.76% 12
2024
Q2 		$24.4M Buy
694,069
+160,554
+30% +$6.36M 2.15% 11
2024
Q1 		$23.4M Sell
533,515
-31,185
-6% -$1.34M 2.06% 16
2023
Q4 		$20.1M Buy
+564,700
New +$16.9M 2.23% 17

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $1.94B AUM 444.09% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return